|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
- Charts Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
